Skip to main content

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.940 +0.090 (+4.86%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 14, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 103,913
Open 1.820
Bid (Size) 1.750 (10)
Ask (Size) 1.970 (5)
Prev. Close 1.850
Today's Range 1.820 - 1.950
52wk Range 1.120 - 4.200
Shares Outstanding 31,056,238
Dividend Yield N/A

Performance

YTD
-41.0%
-41.0%
1 Month
+4.3%
+4.3%
3 Month
-3.0%
-3.0%
6 Month
-27.1%
-27.1%
1 Year
+30.2%
+30.2%

More News

Read More

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 1.940
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 07/14/25 04:00 PM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 60.25M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 60M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.